These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8047684)
21. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome). Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172 [TBL] [Abstract][Full Text] [Related]
22. Leishmania infantum in a Central Italy dog shelter: retrospective study of serologic reactivity during a 4-year period in a confined dog population subjected to preventive and therapeutic treatment. Podaliri Vulpiani M; Iannetti L; Di Mattia T; Dalla Villa P Vet Parasitol; 2009 Mar; 160(3-4):190-7. PubMed ID: 19111991 [TBL] [Abstract][Full Text] [Related]
23. [Survey of Phlebotomus neglectus Tonnoir, 1921 (=P. major s.l.) in a leishmaniasis focus in northern Italy (province of Verona)]. Maroli M; Sansoni L; Bigliocchi F; Khoury C; Valsecchi M Parassitologia; 1995 Dec; 37(2-3):241-4. PubMed ID: 8778665 [TBL] [Abstract][Full Text] [Related]
24. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377 [TBL] [Abstract][Full Text] [Related]
25. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ali A Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830 [TBL] [Abstract][Full Text] [Related]
26. [Visceral leishmaniasis: clinical sensitivity and resistance to various therapeutic agents]. Janvier F; Morillon M; Olliaro P Med Trop (Mars); 2008 Feb; 68(1):89-101. PubMed ID: 18478781 [TBL] [Abstract][Full Text] [Related]
27. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities. Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960 [TBL] [Abstract][Full Text] [Related]
28. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection]. Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648 [TBL] [Abstract][Full Text] [Related]
29. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France]. Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525 [TBL] [Abstract][Full Text] [Related]
30. [The characteristics of the topographical distribution of leishmaniasis in Turkmenistan]. Ponirovskiĭ EN; Charyev BCh Med Parazitol (Mosk); 1996; (1):13-7. PubMed ID: 8700003 [TBL] [Abstract][Full Text] [Related]
31. A new stable focus of canine leishmaniasis in northern Italy. Baldelli R; Battelli G; Maroli M; Mollicone E; Gudi A; Stegagno G; Tasini G Parassitologia; 2001 Dec; 43(4):151-3. PubMed ID: 12402521 [TBL] [Abstract][Full Text] [Related]
32. [Visceral leishmaniasis and HIV infection in the HAART era]. Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494 [TBL] [Abstract][Full Text] [Related]
34. Current diagnosis and treatment of visceral leishmaniasis. Mondal S; Bhattacharya P; Ali N Expert Rev Anti Infect Ther; 2010 Aug; 8(8):919-44. PubMed ID: 20695748 [TBL] [Abstract][Full Text] [Related]
35. [Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy]. Colomba C; Scarlata F; Salsa L; Frasca Polara V; Titone L Infez Med; 2004 Jun; 12(2):139-43. PubMed ID: 15316302 [TBL] [Abstract][Full Text] [Related]
36. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404 [TBL] [Abstract][Full Text] [Related]
37. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852 [TBL] [Abstract][Full Text] [Related]
38. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811 [TBL] [Abstract][Full Text] [Related]
39. Management of visceral leishmaniasis: Indian perspective. Agrawal S; Rai M; Sundar S J Postgrad Med; 2005; 51 Suppl 1():S53-7. PubMed ID: 16519257 [TBL] [Abstract][Full Text] [Related]
40. A review of leishmaniasis in Dalmatia (Croatia) and results from recent surveys on phlebotomine sandflies in three southern counties. Bosnić S; Gradoni L; Khoury C; Maroli M Acta Trop; 2006 Aug; 99(1):42-9. PubMed ID: 16876101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]